inforMED
OtherFKT

2008 SORBENT SYSTEM

Received Dec 14, 2010 · Event occurred Nov 10, 2010

Report 3005778453-2010-00001 · MDR key 1929832

Add to watch list
Product code (FKT)
Manufacturer (Nipro Renal Solutions Usa, Corporation)
Model (NA)

Device

Generic name

Dialysate Delivery, Sorbent Regenerative

Manufacturer

Renal Solutions

Model number

NA

Catalog number

NA

Lot number

NA

Product problems

  • Patient-Device Incompatibility

Patient

48 YR

  • Hemoconcentration
  • Edema
  • High Blood Pressure/ Hypertension
  • Low Blood Pressure/ Hypotension
  • Itching Sensation
  • Nausea
  • Swelling
  • Tachycardia
  • Burning Sensation
  • Reaction

Narrative

Description of Event or Problem

A PT WAS BEING DIALYZED ON THE 2008 SORBENT SYSTEM AND COMPLAINED OF ITCHING OF THEIR HANDS AND FEET THREE MINUTES IN THE TREATMENT. THE PT COMPLAINED THAT THEIR TONGUE AND LIPS WERE BURNING. THE 2008 SORBENT SYSTEM WAS PLACED IN "PAUSE" MODE. THE PHYSICIAN WAS PRESENT AND INSTRUCTED THE PT CARE TECH TO RINSE BACK THE PT'S BLOOD AND THUS CEASE THE DIALYSIS TREATMENT. THE PT CONTINUED TO COMPLAIN OF BURNING IN THEIR THROAT, THEN NAUSEA. IT WAS NOTED THAT THE PT'S EYES, LIPS, AND FACE HAD SOME SWELLING. THE PT'S BLOOD PRESSURE AT THE TIME WAS 57/33, AN EKG REPORTED SINUS TACHYCARDIA OF 147 BPM. BLOOD PRESSURE HAD BEEN 126/92, AND HEART RATE 85/MIN JUST BEFORE START OF DIALYSIS. A 50MG OF DIPHENHYDRAMINE WAS GIVEN IVP AND THE PT WAS PLACED ON O2 AT 2L/MIN. THE PT WAS ALERT AND ORIENTED THROUGHOUT THE INCIDENT. THE PT WAS PLACED ON A SINGLE PASS SYSTEM AND DIALYZED AS PER THEIR USUAL DIALYSIS TREATMENT. THE PT WAS OBSERVED DURING DIALYSIS BY THE PHYSICIAN. AT THE END OF THE DIALYSIS TREATMENT, VITAL SIGNS HAD RETURNED TO NORMAL AND ASIDE FROM SLIGHT EDEMA OF THE PT'S EYES AND THE PT'S SYMPTOMS HAD SUBSIDED. THE PT WAS DISCHARGED HOME. AFTER THE PT WAS TAKEN OFF OF THE DEVICE, IT WAS CONCLUDED THAT THE PT HAD IDIOSYNCRATIC REACTION TO THE DIALYSIS PROCEDURE AS EVIDENCE BY ITCHINESS, FACIAL SWELLING AND TACHYCARDIA. THE PT ALSO SHOWED SIGNS OF HYPERTENSION WHICH ENSUED AFTER IV BENADRYL WAS PROVIDED. NO PERMANENT SEQUELAE OF THE INCIDENT WAS OBSERVED. THE ANALYSIS OF THE LABORATORY DATA OBTAINED DURING THIS SEQUENCE OF EVENTS INDICATED HEMOCONCENTRATION, AS EVIDENCE BY A RISE OF HEMATOCRIT FROM 30% PRE-TREATMENT TO WITH THE SORB 2008 MACHINE; IT ROSE TO 36% AFTER 7 MINUTES INTO TREATMENT AND SUBSEQUENTLY ROSE TO 42%. THE LAST OBSERVED HEMATOCRIT WAS AT THE END OF TREATMENT WAS 40% AND LEVELS OF HISTAMINE, IGE, C3, AND C4 WERE NORMAL.

Additional Manufacturer Narrative

THE 2008 SORBENT SYSTEM WAS EVALUATED BY THE USER FACILITY BIO-TECHNICIAN AS THEY WERE TRAINED TO SERVICE AND VERIFY OPERATION OF THE SYSTEM. THE 2008 SORBENT SYSTEM (B)(4) WAS EVALUATED AND FOUND TO BE OPERATING WITHIN THE EXPECTED AS INDICATED BELOW: OPERATION OF THE DEVICE WAS VERIFIED ONE DAY AFTER THE INCIDENT BY THE USER FACILITY BIO-TECHNICIAN; THE DEVICE WAS SETUP AND A MOCK PT TREATMENT WAS RUN ON IT. THE UNIT HAD NO RECORDED ISSUES AND ALL OF THE FUNCTIONAL PARAMETERS INDICATED THAT THE 2008 SORBENT SYSTEM OPERATED DURING THE MOCK PT TREATMENT AS DESIGNED. THE CONSOLE LOGS FROM THE MOCK PT TREATMENT WERE PULLED FROM THE DEVICE AND EVALUATED BY THE RENAL SOLUTIONS.